InMed Pharmaceuticals Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
INM on Nasdaq
Location
1445 885 West Georgia St., Vancouver, British Columbia, Canada

Insiders trading volume in the past year

InMed Pharmaceuticals Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Eric A. Adams President & CEO, Director $15.8K +$14.9K +1764% May 27, 2024
Andrew Hull Director $14.9K +$14.6K +4941% Feb 21, 2024
Bruce Colwill Cfo $10.3K Jan 24, 2022
Alexandra Diane Janet Mancini Consultant $0 -$42 -100% Jul 31, 2024
Eric C. Hsu Sr. VP, Pre-Clinical Res/Dev May 27, 2024
Michael Woudenberg Chief Operating Officer May 27, 2024
Shane Johnson Sr VP & General Manager Dec 23, 2023
Catherine Sazdanoff Director Dec 29, 2021
Sarah Li VP Accounting & Controller Dec 16, 2022
Jonathan Tegge Interim CFO Dec 23, 2023
Nicole Lemerond Director Dec 23, 2023
Janet Grove Director Dec 23, 2023
Brenda Edwards Interim CFO Apr 1, 2022
Bryan Baldasare Director Dec 23, 2023
William J. Garner Director Jan 24, 2022
Adam D. Cutler Director Jan 24, 2022
Netta Jagpal Chief Financial Officer Feb 20, 2024

Recent Insider Transactions by Companies or Individuals for InMed Pharmaceuticals Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.